IDEAYA Biosciences Inc.

NASDAQ: IDYA · Real-Time Price · USD
24.33
-0.04 (-0.16%)
At close: Aug 15, 2025, 3:59 PM
24.33
0.00%
After-hours: Aug 15, 2025, 04:54 PM EDT

IDEAYA Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
7M 7M 7M 3.92M 11.96M 15.51M 23.39M 23.48M 45.15M 47.45M 50.93M 49.87M 29.15M 32.05M 27.94M 35.55M 35.54M 26.79M
Cost of Revenue
643K 1.74M 2.82M 3.2M 4.19M 4.09M 3.97M 3.5M 3.44M 3.65M 3.15M 3.02M 17.6M 31.37M 42.47M 54.1M 48.62M 42.24M
Gross Profit
6.36M 5.26M 4.18M 720K 7.77M 11.41M 19.42M 19.98M 41.7M 43.8M 47.78M 46.85M 11.55M 683K -14.53M -18.55M -13.08M -15.45M
Operating Income
-384.23M -360.35M -326.98M -224.75M -191.38M -159.17M -134.43M -118.96M -84.77M -74.56M -62.5M -54.43M -66.8M -55.35M -50.27M -37.18M -30.46M -32M
Interest Income
41.11M 53.26M 52.5M 46.63M 37.65M 30.28M 21.47M 15.75M 10.62M 6.28M 3.85M 1.76M 938K 599K 506K 494K 433K 528K
Pretax Income
-331.03M -306.31M -274.48M -178.12M -153.74M -128.89M -112.96M -103.21M -74.15M -68.28M -60.75M -54.76M -67.95M -56.85M -49.76M -36.69M -30.03M -31.47M
Net Income
-331.03M -306.31M -274.48M -178.12M -153.74M -128.89M -109.36M -97.37M -67.36M -61.04M -58.99M -55.24M -69.4M -58.73M -49.76M -36.69M -30.03M -31.47M
Selling & General & Admin
48.78M 43.5M 38.2M 34.32M 32.44M 30.22M 28.31M 26.99M 25.79M 24.27M 23.9M 23.37M 21.89M 21.16M 20.05M 18.63M 17.38M 16.55M
Research & Development
342.45M 322.75M 294.67M 193.26M 169.81M 144.45M 129.51M 115.45M 104.12M 97.74M 89.54M 80.93M 74.06M 66.25M 58.16M 54.1M 48.62M 42.24M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.42M -4.42M -4.42M -4.42M n/a n/a n/a
Operating Expenses
391.23M 366.25M 332.88M 227.58M 202.25M 174.67M 157.81M 142.44M 129.92M 122.01M 113.43M 104.3M 95.95M 87.41M 78.21M 72.73M 66M 58.79M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -1.1M -1.1M -1.1M -1.1M -1K -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
302.42M 367.35M 333.98M 228.68M 203.35M 174.67M 157.81M 142.44M 129.92M 122.01M 113.43M 104.3M 95.95M 87.41M 78.21M 72.73M 66M 58.79M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -3.6M -5.84M -6.8M -7.24M -1.75M 487K 1.44M 1.93M 44K 44K 44K n/a
Shares Outstanding (Basic)
88.47M 88.36M 87.34M 86.19M 77.96M 75.11M 65.25M 60M 56.25M 48.37M 48.13M 40.3M 38.66M 38.59M 38.36M 37.36M 32.85M 31.76M
Shares Outstanding (Diluted)
88.47M 88.36M 87.34M 86.19M 77.96M 75.11M 65.25M 60M 56.25M 48.37M 48.13M 41.11M 38.66M 38.59M 38.5M 37.77M 32.85M 31.76M
EPS (Basic)
-3.79 -3.59 -3.3 -2.33 -2.19 -2.01 -1.89 -1.83 -1.31 -1.37 -1.43 -1.44 -1.81 -1.58 -1.39 -1.1 -0.96 -1.22
EPS (Diluted)
-3.79 -3.59 -3.3 -2.33 -2.19 -2.01 -1.89 -1.83 -1.31 -1.37 -1.43 -1.44 -1.81 -1.58 -1.39 -1.1 -0.96 -1.22
EBITDA
-382.45M -357.95M -325.09M -222.89M -188.88M -156.66M -131.96M -116.55M -82.08M -71.63M -59.7M -51.6M -64.44M -53.41M -48.41M -35.54M -28.93M -30.57M
EBIT
-372.91M -360.35M -326.98M -224.75M -191.39M -159.17M -134.43M -118.96M -84.77M -74.56M -62.5M -54.43M -66.8M -55.35M -50.27M -37.18M -30.46M -32M
Depreciation & Amortization
2.79M 3.88M 3.83M 4.21M 4.19M 4.09M 3.97M 3.5M 3.44M 3.65M 3.15M 3.02M 2.59M 1.79M 1.71M 1.64M 1.49M 1.43M